Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Marc E. Rothenberg, Arsalan Shabbir, Elizabeth Laws et al.|˜The œLancet. Gastroenterology & hepatology|2023

Cited by 100